# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY

I Background Information:

A 510(k) Number K203527   
B Applicant Immunalysis Corporation   
C Proprietary and Established Names Immunalysis Tapentadol Urine HEIATM   
D Regulatory Information

<table><tr><td rowspan=1 colspan=1>ProductCode(s)</td><td rowspan=1 colspan=1>Classification</td><td rowspan=1 colspan=1>RegulationSection</td><td rowspan=1 colspan=1>Panel</td></tr><tr><td rowspan=1 colspan=1>DJG</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR 862.3650 -Opiate Test System</td><td rowspan=1 colspan=1>TX - ClinicalToxicology</td></tr></table>

II Submission/Device Overview:

A Purpose for Submission: New Device   
B Measurand: Tapentadol   
C Type of Test: Qualitative and Semi-quantitative Enzyme Immunoassay

# III Intended Use/Indications for Use:

A Intended Use(s): See Indications for Use below.

# B Indication(s) for Use:

For in vitro diagnostic use.

The Immunalysis Tapentadol Urine HEIATM is a homogeneous enzyme immunoassay with a cutoff of $2 0 0 ~ \mathrm { { n g / m L } }$ . The assay is intended for use in laboratories for the qualitative and semiquantitative analysis of tapentadol in human urine with automated clinical chemistry analyzers. This assay is calibrated against tapentadol. This in vitro diagnostic device is for prescription use only.

The Immunalysis Tapentadol Urine HEIATM provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas Chromatography/ Mass Spectrometry (GC-MS) or Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) is the preferred confirmatory method.

Clinical consideration and professional judgment should be applied to any test result, particularly when preliminary positive results are used.

The semi-quantitative mode is for purposes of enabling laboratories to determine an appropriate dilution of the specimen for confirmation using a confirmatory method such as Gas Chromatography/ Mass Spectrometry (GC-MS) or Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).

C Special Conditions for Use Statement(s): Rx - For Prescription Use Only

# D Special Instrument Requirements:

Beckman Coulter AU 480 chemistry analyzer.

# IV Device/System Characteristics:

# A Device Description:

The Immunalysis Tapentadol Urine HEIATM consists of ready to use reagents as follows:

1 bottle $2 5 ~ \mathrm { m L }$ , $6 0 \mathrm { m L }$ , $1 0 0 ~ \mathrm { m L }$ , or $5 0 0 ~ \mathrm { m L }$ ) of Antibody/Substrate Reagent (Reagent A) containing recombinant antibodies to Tapentadol, glucose-6-phosphate (G6P) and nicotinamide adenine dinucleotide (NAD) $( < 0 . 5 \% )$ in Tris buffer with Sodium Azide as a preservative. • 1 bottle ( $2 5 ~ \mathrm { m L }$ , $6 0 ~ \mathrm { m L }$ , $1 0 0 ~ \mathrm { m L }$ , or $5 0 0 ~ \mathrm { m L }$ ) of Enzyme Conjugate Reagent (Reagent E) containing glucose-6-phosphate dehydrogenase (G6PDH) labeled with tapentadol $( < 0 . 5 \% )$ in Tris buffer with Sodium Azide as a preservative.

# B Principle of Operation:

The assay is based on the competition of tapentadol labeled enzyme glucose-6-phosphate dehydrogenase (G6PDH) and the free drug in the urine sample for the fixed amount of rabbit anti-tapentadol antibody binding sites. In the absence of the free drug in the sample, the antibody binds the drug enzyme conjugate and enzyme activity is inhibited. This creates a dose response relationship between drug concentration in the urine and enzyme activity. The enzyme G6PDH activity is determined at $3 4 0 \mathrm { n m }$ spectrophotometrically by the conversion of NAD to NADH.

# V Substantial Equivalence Information:

A Predicate Device Name(s): Immunalysis Tramadol Urine Enzyme Immunoassay   
B Predicate 510(k) Number(s): K141803

# C Comparison with Predicate(s):

<table><tr><td rowspan=1 colspan=1>Device &amp; PredicateDevice(s):</td><td rowspan=1 colspan=1>K203527</td><td rowspan=1 colspan=1>K141803</td></tr><tr><td rowspan=1 colspan=1>Device Trade Name</td><td rowspan=1 colspan=1>ImmunalysisTapentadol UrineHEIATM</td><td rowspan=1 colspan=1>Immunalysis Tramadol EnzymeImmunoassay</td></tr><tr><td rowspan=1 colspan=1>General DeviceCharacteristic Similarities</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1>For the qualitative and semi-quantitative analysis of an opioidin human urine with automatedclinical chemistry analyzers.</td></tr><tr><td rowspan=1 colspan=1>Test Principle</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1>Homogeneous enzymeimmunoassay</td></tr><tr><td rowspan=1 colspan=1>User Environment</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1>For use in laboratories</td></tr><tr><td rowspan=1 colspan=1>Sample Matrix</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1>Human urine</td></tr><tr><td rowspan=1 colspan=1>Mass SpectrometryConfirmation</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1>Required for preliminary positiveanalytical results</td></tr><tr><td rowspan=1 colspan=1>General DeviceCharacteristic Differences</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Antibody</td><td rowspan=1 colspan=1>Recombinant FABantibody to Tapentadol</td><td rowspan=1 colspan=1>Goat Polyclonal Antibody toTramadol</td></tr><tr><td rowspan=1 colspan=1>Calibrator</td><td rowspan=1 colspan=1>Tapentadol</td><td rowspan=1 colspan=1>Tramadol</td></tr></table>

# VI Standards/Guidance Documents Referenced:

• ISO 14971:2007 Medical Devices – Application of Risk Management to Medical Devices • EN ISO 14971:2012 Medical Devices – Application of Risk Management to Medical Devices

# VII Performance Characteristics (if/when applicable):

# A Analytical Performance:

1. Precision/Reproducibility:

A precision study was performed over 20 days, two runs per day in duplicates $( 2 0 \times 2 \times 2$ replicates per panel member) for a total of 80 replicates $( \mathrm { N } { = } 8 0 )$ ) per sample on 3 lots of reagent. Nine panel members were prepared using drug free negative urine as the base sample and 8 panel members were spiked to concentrations of assay cutoff and $\pm 2 5 \% , \pm 5 0 \%$ , $\pm 7 5 \%$ , $\pm 1 0 0 \%$ of the cutoff $( 2 0 0 ~ \mathrm { n g / m L } )$ . The concentrations used for spiking were confirmed by liquid chromatography tandem mass spectrometry (LC-MS/MS).

Summary of Precision – Qualitative   

<table><tr><td colspan="1" rowspan="1">Concentration(ng/mL)</td><td colspan="1" rowspan="1">% of cutoff</td><td colspan="1" rowspan="1"># of determinations</td><td colspan="1" rowspan="1">Result</td></tr><tr><td colspan="4" rowspan="1">Lot# 1</td></tr><tr><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">-100%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">80 Negative</td></tr><tr><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">-75%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">80 Negative</td></tr><tr><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">-50%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">80 Negative</td></tr><tr><td colspan="1" rowspan="1">150</td><td colspan="1" rowspan="1">-25%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">80 Negative</td></tr><tr><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">Cutoff</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">41 Neg / 39 Pos</td></tr><tr><td colspan="1" rowspan="1">250</td><td colspan="1" rowspan="1">+25%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">80 Positive</td></tr><tr><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">+50%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">80 Positive</td></tr><tr><td colspan="1" rowspan="1">350</td><td colspan="1" rowspan="1">+75%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">80 Positive</td></tr><tr><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">+100%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">80 Positive</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="2" rowspan="1">Lot# 2</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">-100%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">80 Negative</td></tr><tr><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">-75%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">80 Negative</td></tr><tr><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">-50%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">80 Negative</td></tr><tr><td colspan="1" rowspan="1">150</td><td colspan="1" rowspan="1">-25%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">80 Negative</td></tr><tr><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">Cutoff</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">35 Neg / 45 Pos</td></tr><tr><td colspan="1" rowspan="1">250</td><td colspan="1" rowspan="1">+25%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">80 Positive</td></tr><tr><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">+50%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">80 Positive</td></tr><tr><td colspan="1" rowspan="1">350</td><td colspan="1" rowspan="1">+75%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">80 Positive</td></tr><tr><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">+100%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">80 Positive</td></tr><tr><td colspan="4" rowspan="1">Lot# 3</td></tr><tr><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">-100%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">80 Negative</td></tr><tr><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">-75%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">80 Negative</td></tr><tr><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">-50%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">80 Negative</td></tr><tr><td colspan="1" rowspan="1">150</td><td colspan="1" rowspan="1">-25%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">80 Negative</td></tr><tr><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">Cutoff</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">42 Neg / 38 Pos</td></tr><tr><td colspan="1" rowspan="1">250</td><td colspan="1" rowspan="1">+25%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">80 Positive</td></tr><tr><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">+50%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">80 Positive</td></tr><tr><td colspan="1" rowspan="1">350</td><td colspan="1" rowspan="1">+75%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">80 Positive</td></tr><tr><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">+100%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">80 Positive</td></tr></table>

Summary of Precision - Semi-Quantitative   

<table><tr><td colspan="1" rowspan="1">Concentration(ng/mL)</td><td colspan="1" rowspan="1">% ofcutoff</td><td colspan="1" rowspan="1"># ofdeterminations</td><td colspan="1" rowspan="1">MeanConc.(ng/mL)</td><td colspan="1" rowspan="1">QualitativeInterpretativeResult</td><td colspan="1" rowspan="1">SD</td><td colspan="1" rowspan="1">CV (%)</td></tr><tr><td colspan="7" rowspan="1">Lot# 1</td></tr><tr><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">-100%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">-3</td><td colspan="1" rowspan="1">80 Negative</td><td colspan="1" rowspan="1">8.0</td><td colspan="1" rowspan="1">N/A</td></tr><tr><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">-75%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">48</td><td colspan="1" rowspan="1">80 Negative</td><td colspan="1" rowspan="1">4.7</td><td colspan="1" rowspan="1">9.7</td></tr><tr><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">-50%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">99</td><td colspan="1" rowspan="1">80 Negative</td><td colspan="1" rowspan="1">7.5</td><td colspan="1" rowspan="1">7.6</td></tr><tr><td colspan="1" rowspan="1">150</td><td colspan="1" rowspan="1">-25%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">161</td><td colspan="1" rowspan="1">80 Negative</td><td colspan="1" rowspan="1">5.8</td><td colspan="1" rowspan="1">3.6</td></tr><tr><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">Cutoff</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">215</td><td colspan="1" rowspan="1">2 Neg / 78 Pos</td><td colspan="1" rowspan="1">8.6</td><td colspan="1" rowspan="1">4.0</td></tr><tr><td colspan="1" rowspan="1">250</td><td colspan="1" rowspan="1">+25%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">268</td><td colspan="1" rowspan="1">80 Positive</td><td colspan="1" rowspan="1">10.0</td><td colspan="1" rowspan="1">3.7</td></tr><tr><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">+50%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">304</td><td colspan="1" rowspan="1">80 Positive</td><td colspan="1" rowspan="1">17.6</td><td colspan="1" rowspan="1">5.8</td></tr><tr><td colspan="1" rowspan="1">350</td><td colspan="1" rowspan="1">+75%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">372</td><td colspan="1" rowspan="1">80 Positive</td><td colspan="1" rowspan="1">25.4</td><td colspan="1" rowspan="1">6.8</td></tr><tr><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">+100%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">431</td><td colspan="1" rowspan="1">80 Positive</td><td colspan="1" rowspan="1">25.2</td><td colspan="1" rowspan="1">5.9</td></tr><tr><td colspan="3" rowspan="1"></td><td colspan="1" rowspan="1">Lot# 2</td><td colspan="1" rowspan="1"></td><td colspan="2" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">-100%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">-4</td><td colspan="1" rowspan="1">80 Negative</td><td colspan="1" rowspan="1">8.9</td><td colspan="1" rowspan="1">N/A</td></tr><tr><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">-75%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">80 Negative</td><td colspan="1" rowspan="1">4.8</td><td colspan="1" rowspan="1">9.7</td></tr><tr><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">-50%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">80 Negative</td><td colspan="1" rowspan="1">7.8</td><td colspan="1" rowspan="1">7.7</td></tr><tr><td colspan="1" rowspan="1">150</td><td colspan="1" rowspan="1">-25%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">162</td><td colspan="1" rowspan="1">80 Negative</td><td colspan="1" rowspan="1">7.6</td><td colspan="1" rowspan="1">4.7</td></tr><tr><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">Cutoff</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">213</td><td colspan="1" rowspan="1">8 Neg / 72 Pos</td><td colspan="1" rowspan="1">10.6</td><td colspan="1" rowspan="1">5.0</td></tr><tr><td colspan="1" rowspan="1">250</td><td colspan="1" rowspan="1">+25%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">263</td><td colspan="1" rowspan="1">80 Positive</td><td colspan="1" rowspan="1">12.3</td><td colspan="1" rowspan="1">4.7</td></tr><tr><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">+50%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">298</td><td colspan="1" rowspan="1">80 Positive</td><td colspan="1" rowspan="1">17.6</td><td colspan="1" rowspan="1">5.9</td></tr><tr><td colspan="1" rowspan="1">350</td><td colspan="1" rowspan="1">+75%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">359</td><td colspan="1" rowspan="1">80 Positive</td><td colspan="1" rowspan="1">20.2</td><td colspan="1" rowspan="1">5.6</td></tr><tr><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">+100%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">417</td><td colspan="1" rowspan="1">80 Positive</td><td colspan="1" rowspan="1">21.7</td><td colspan="1" rowspan="1">5.2</td></tr><tr><td colspan="4" rowspan="1">Lot# 3</td><td colspan="3" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">-100%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">-3</td><td colspan="1" rowspan="1">80 Negative</td><td colspan="1" rowspan="1">7.1</td><td colspan="1" rowspan="1">N/A</td></tr><tr><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">-75%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">49</td><td colspan="1" rowspan="1">80 Negative</td><td colspan="1" rowspan="1">4.4</td><td colspan="1" rowspan="1">8.9</td></tr><tr><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">-50%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">102</td><td colspan="1" rowspan="1">80 Negative</td><td colspan="1" rowspan="1">6.9</td><td colspan="1" rowspan="1">6.8</td></tr><tr><td colspan="1" rowspan="1">150</td><td colspan="1" rowspan="1">-25%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">162</td><td colspan="1" rowspan="1">80 Negative</td><td colspan="1" rowspan="1">6.1</td><td colspan="1" rowspan="1">3.8</td></tr><tr><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">Cutoff</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">215</td><td colspan="1" rowspan="1">7 Neg / 73 Pos</td><td colspan="1" rowspan="1">9.7</td><td colspan="1" rowspan="1">4.5</td></tr><tr><td colspan="1" rowspan="1">250</td><td colspan="1" rowspan="1">+25%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">266</td><td colspan="1" rowspan="1">80 Positive</td><td colspan="1" rowspan="1">9.9</td><td colspan="1" rowspan="1">3.7</td></tr><tr><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">+50%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">303</td><td colspan="1" rowspan="1">80 Positive</td><td colspan="1" rowspan="1">16.0</td><td colspan="1" rowspan="1">5.3</td></tr><tr><td colspan="1" rowspan="1">350</td><td colspan="1" rowspan="1">+75%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">369</td><td colspan="1" rowspan="1">80 Positive</td><td colspan="1" rowspan="1">20.7</td><td colspan="1" rowspan="1">5.6</td></tr><tr><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">+100%</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">422</td><td colspan="1" rowspan="1">80 Positive</td><td colspan="1" rowspan="1">20.6</td><td colspan="1" rowspan="1">4.9</td></tr></table>

2. Linearity:

A linearity study in the semi-quantitative mode was conducted by spiking a drug free urine pool with a high concentration of tapentadol above the highest calibrator. Additional linearity samples were made by serially diluting the high concentration specimen with drug free urine to achieve concentrations ranging from 100 to $1 1 0 0 ~ \mathrm { { n g / m L } }$ . The $0 \mathrm { n g / m L }$ specimen was made from drug free urine. Each pool was tested in triplicate to calculate the mean concentration values that were used to calculate drug recovery of tapentadol. The assay drug recovery percentage ranged from 95.8 to $1 1 0 . 4 \%$ . Linearity test results in semi-quantitative mode are presented below.

Linearity/Recovery – Tapentadol   

<table><tr><td rowspan=1 colspan=1>ExpectedConcentration(ng/mL)</td><td rowspan=1 colspan=1>MeanConcentration(ng/mL)</td><td rowspan=1 colspan=1>Recovery (%)</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>3.0</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>110.4</td><td rowspan=1 colspan=1>110.4</td></tr><tr><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>211.6</td><td rowspan=1 colspan=1>105.8</td></tr><tr><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>298.2</td><td rowspan=1 colspan=1>99.4</td></tr><tr><td rowspan=1 colspan=1>400</td><td rowspan=1 colspan=1>417.3</td><td rowspan=1 colspan=1>104.3</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>531.2</td><td rowspan=1 colspan=1>106.2</td></tr><tr><td rowspan=1 colspan=1>600</td><td rowspan=1 colspan=1>614.1</td><td rowspan=1 colspan=1>102.4</td></tr><tr><td rowspan=1 colspan=1>700</td><td rowspan=1 colspan=1>721.7</td><td rowspan=1 colspan=1>103.1</td></tr><tr><td rowspan=1 colspan=1>800</td><td rowspan=1 colspan=1>827.3</td><td rowspan=1 colspan=1>103.4</td></tr><tr><td rowspan=1 colspan=1>900</td><td rowspan=1 colspan=1>907.8</td><td rowspan=1 colspan=1>100.9</td></tr><tr><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>980.1</td><td rowspan=1 colspan=1>98.0</td></tr><tr><td rowspan=1 colspan=1>1100</td><td rowspan=1 colspan=1>1054.3</td><td rowspan=1 colspan=1>95.8</td></tr></table>

# Cross Reactivity

Structurally and functionally similar compounds were spiked into drug free urine at levels that will yield a result that is equivalent to the cutoff. The data demonstrates all sample compounds tested were negative by both the qualitative and semi-quantitative interpretations except for N-desmethyl tapentadol and tapentadol glucuronide. The $\%$ of cross- reactivity of the semi-quantitative results was $< 0 . 2 \%$ for all compounds tested except for N-desmethyl tapentadol with $1 5 . 7 \%$ and tapentadol glucuronide with $0 . 5 \%$ of cross- reactivity. Crossreactivity test results in qualitative mode and semi-quantitative mode are presented in below.

Cross-Reactivity – Qualitative   

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>CompoundConc. ng/mL)</td><td rowspan=1 colspan=1>TapentadolEquivalentConc.(ng/mL)</td><td rowspan=1 colspan=1>Result</td><td rowspan=1 colspan=1>Cross-Reactivity(%)</td></tr><tr><td rowspan=1 colspan=1>Chlorpromazine</td><td rowspan=1 colspan=1>100,000</td><td rowspan=1 colspan=1>&lt;200</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>&lt;0.2</td></tr><tr><td rowspan=1 colspan=1>Clomipramine</td><td rowspan=1 colspan=1>100,000</td><td rowspan=1 colspan=1>&lt;200</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>&lt;0.2</td></tr><tr><td rowspan=1 colspan=1>Cyclobenzaprine</td><td rowspan=1 colspan=1>100,000</td><td rowspan=1 colspan=1>&lt;200</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>&lt;0.2</td></tr><tr><td rowspan=1 colspan=1>Doxepin</td><td rowspan=1 colspan=1>100,000</td><td rowspan=1 colspan=1>&lt;200</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>&lt;0.2</td></tr><tr><td rowspan=1 colspan=1>Imipramine</td><td rowspan=1 colspan=1>100,000</td><td rowspan=1 colspan=1>&lt;200</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>&lt;0.2</td></tr><tr><td rowspan=1 colspan=1>O-desmethyl tramadol</td><td rowspan=1 colspan=1>100,000</td><td rowspan=1 colspan=1>&lt;200</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>&lt;0.2</td></tr><tr><td rowspan=1 colspan=1>O-desmethyl venlafaxine</td><td rowspan=1 colspan=1>100,000</td><td rowspan=1 colspan=1>&lt;200</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>&lt;0.2</td></tr><tr><td rowspan=1 colspan=1>N-desmethyl tapentadol</td><td rowspan=1 colspan=1>1,275</td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>15.7</td></tr><tr><td rowspan=1 colspan=1>N-desmethyl tramadol</td><td rowspan=1 colspan=1>100,000</td><td rowspan=1 colspan=1>&lt;200</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>&lt;0.2</td></tr><tr><td rowspan=1 colspan=1>N-desmethyl venlafaxine</td><td rowspan=1 colspan=1>100,000</td><td rowspan=1 colspan=1>&lt;200</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>&lt;0.2</td></tr><tr><td rowspan=1 colspan=1>Tapentadol glucuronide</td><td rowspan=1 colspan=1>43,000</td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>0.5</td></tr><tr><td rowspan=1 colspan=1>Tramadol</td><td rowspan=1 colspan=1>100,000</td><td rowspan=1 colspan=1>&lt;200</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>&lt;0.2</td></tr><tr><td rowspan=1 colspan=1>Trimipramine</td><td rowspan=1 colspan=1>100,000</td><td rowspan=1 colspan=1>&lt;200</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>&lt;0.2</td></tr><tr><td rowspan=1 colspan=1>Venlafaxine</td><td rowspan=1 colspan=1>100,000</td><td rowspan=1 colspan=1>&lt;200</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>&lt;0.2</td></tr></table>

Cross-Reactivity – Semi-Quantitative   

<table><tr><td colspan="1" rowspan="1">Compound</td><td colspan="1" rowspan="1">CompoundConc.(ng/mL)</td><td colspan="1" rowspan="1">TapentadolEquivalentConc.(ng/mL)</td><td colspan="1" rowspan="1">MeanValue(ng/mL)</td><td colspan="1" rowspan="1">Result</td><td colspan="1" rowspan="1">Cross-Reactivity(%)</td></tr><tr><td colspan="1" rowspan="1">Chlorpromazine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt; 200</td><td colspan="1" rowspan="1">47.3</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">&lt;0.2</td></tr><tr><td colspan="1" rowspan="1">Clomipramine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;200</td><td colspan="1" rowspan="1">47.6</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">&lt;0.2</td></tr><tr><td colspan="1" rowspan="1">Cyclobenzaprine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;200</td><td colspan="1" rowspan="1">1.0</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">&lt;0.2</td></tr><tr><td colspan="1" rowspan="1">Doxepin</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;200</td><td colspan="1" rowspan="1">0.9</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">&lt;0.2</td></tr><tr><td colspan="1" rowspan="1">Imipramine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;200</td><td colspan="1" rowspan="1">69.7</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">&lt;0.2</td></tr><tr><td colspan="1" rowspan="1">Compound</td><td colspan="1" rowspan="1">Compound TapentadolConc.(ng/mL)</td><td colspan="1" rowspan="1">Compound TapentadolEquivalentConc.(ng/mL)</td><td colspan="1" rowspan="1">MeanValue(ng/mL)</td><td colspan="1" rowspan="1">Result</td><td colspan="1" rowspan="1">Cross-Reactivity(%)</td></tr><tr><td colspan="1" rowspan="1">O-desmethyl tramadol</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;200</td><td colspan="1" rowspan="1">101.0</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">&lt;0.2</td></tr><tr><td colspan="1" rowspan="1">O-desmethyl venlafaxine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;200</td><td colspan="1" rowspan="1">1.8</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">&lt;0.2</td></tr><tr><td colspan="1" rowspan="1">N-desmethyl tapentadol</td><td colspan="1" rowspan="1">1,275</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">214.3</td><td colspan="1" rowspan="1">POS</td><td colspan="1" rowspan="1">15.7</td></tr><tr><td colspan="1" rowspan="1">N-desmethyl tramadol</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;200</td><td colspan="1" rowspan="1">6.0</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">&lt;0.2</td></tr><tr><td colspan="1" rowspan="1">N-desmethyl venlafaxine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;200</td><td colspan="1" rowspan="1">1.9</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">&lt;0.2</td></tr><tr><td colspan="1" rowspan="1">Tapentadol glucuronide</td><td colspan="1" rowspan="1">43,000</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">211.7</td><td colspan="1" rowspan="1">POS</td><td colspan="1" rowspan="1">0.5</td></tr><tr><td colspan="1" rowspan="1">Tramadol</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;200</td><td colspan="1" rowspan="1">2.5</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">&lt;0.2</td></tr><tr><td colspan="1" rowspan="1">Trimipramine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;200</td><td colspan="1" rowspan="1">10.8</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">&lt;0.2</td></tr><tr><td colspan="1" rowspan="1">Venlafaxine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;200</td><td colspan="1" rowspan="1">-1.6</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">&lt;0.2</td></tr></table>

# Interference – Structurally Unrelated Compounds

Structurally unrelated compounds were evaluated in qualitative and semi-quantitative modes by spiking the potential interferent into drug free urine containing tapentadol at $\pm 2 5 \%$ of the cutoff. The levels of structurally unrelated compounds that did not interfere in the assay are presented below.

Non-Interfering Structurally Unrelated Compounds   

<table><tr><td colspan="1" rowspan="1">Compound</td><td colspan="1" rowspan="1">Conc. Tested(ng/mL)</td></tr><tr><td colspan="1" rowspan="1">4-Bromo-2,5,Dimethoxyphenethylamine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">6-Acetylcodeine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">6-Acetylmorphine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Alprazolam</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">7-Aminoclonazepam</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">7-Aminoflunitrazepam</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">7-Aminonitrazepam</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Amitriptyline</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">d-Amphetamine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Amobarbital</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Atomoxetine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Benzoylecgonine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Benzylpiperazine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Bromazepam</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Brompheniramine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Buprenorphine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Bupropion</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Butabarbital</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Butalbital</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Cannabidiol</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Cannabinol</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Carbamazepine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Cetirizine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Chlordiazepoxide</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">1-(3-Chlorophenylpiperazine) mCPP</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Chlorpheniramine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Cimetidine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Citalopram</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Clobazam</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Clonazepam</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Clozapine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Cocaine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Codeine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Cotinine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Dehydronorketamine</td><td colspan="1" rowspan="1">50,000</td></tr><tr><td colspan="1" rowspan="1">Demoxepam</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Desakylflurazepam</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Desipramine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Dextromethorphan</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Dihydrohydroxcarbamazepine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Digoxin</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Dihydrocodeine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Doxylamine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Duloxetine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Ecgonine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Ecgonine Methyl Ester</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">EDDP</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">EMDP</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">1S,2R (+)-Ephedrine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Ethylmorphine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Ethyl-β-D-Glucuronide</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Fentanyl</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Fenfluramine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Flunitrazepam</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Fluoxetine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Flurazepam</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Haloperidol</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Heroin</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Hexobarbital</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Hydrocodone</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Hydromorphone</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Ketamine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Lamotrigine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Levorphanol</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Lidocaine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Lorazepam</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Lorazepam Glucuronide</td><td colspan="1" rowspan="1">50,000</td></tr><tr><td colspan="1" rowspan="1">Lormetazepam</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">LSD</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Maprotiline</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">MDA</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">MDEA</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">MDMA</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Meperidine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Meprobamate</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">d-Methamphetamine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Methaquolone</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Methoxetamine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Methylone</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Methylphenidate</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Midazolam</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Morphine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Morphine-3-Glucuronide</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Morphine-6-Glucuronide</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Nalorphine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Naloxone</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Naltrexone</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Naproxen</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Nitrazepam</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Norbuprenorphine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Norcodeine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Nordiazepam</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Norketamine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Normorphine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Noroxycodone</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Norpropoxyphene</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Norpseudoephedrine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Nortriptyline</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Olanzapine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Oxazepam glucuronide</td><td colspan="1" rowspan="1">50,000</td></tr><tr><td colspan="1" rowspan="1">Oxycodone</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Oxymorphone</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Delta-9-THC</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">11-hydroxy-delta-9-THC</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">11-nor-9 carboxy THC</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">PCP</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Pentazocine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Pentobarbital</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Phenobarbital</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Phentermine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">R(-)-Phenylephrine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Phenylpropanolamine (PPA)</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Phenytoin</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">PMA</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">PMMA</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Prazepam</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Propoxyphene</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Propranolol</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Protriptyline</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">R,R (-)-Pseudoephedrine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">S,S (+)-Pseudoephedrine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Risperidone</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Ritalinic Acid</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Salicylic Acid</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Secobarbital</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Sertraline</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Sufentanil</td><td colspan="1" rowspan="1">50,000</td></tr><tr><td colspan="1" rowspan="1">Temazepam</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Theophylline</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Thioridazine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Trazadone</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Triazolam</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">3-Trifluoromethylphenyl-piperazine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Tyramine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Verapamil</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Zolpidem</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Carisoprodol</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">1R,2S (-)-Ephedrine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Acetaminophen</td><td colspan="1" rowspan="1">500,000</td></tr><tr><td colspan="1" rowspan="1">Acetylsalicyclic Acid</td><td colspan="1" rowspan="1">500,000</td></tr><tr><td colspan="1" rowspan="1">α-hydroxyalprazolam</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Barbital</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Caffeine</td><td colspan="1" rowspan="1">500,000</td></tr><tr><td colspan="1" rowspan="1">Cyclopentobarbital</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Diphenhydramine</td><td colspan="1" rowspan="1">300,000</td></tr><tr><td colspan="1" rowspan="1">Ibuprofen</td><td colspan="1" rowspan="1">500,000</td></tr><tr><td colspan="1" rowspan="1">LAAM</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Labetalol</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Loratadine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Mephenytoin</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Methadone</td><td colspan="1" rowspan="1">500,000</td></tr><tr><td colspan="1" rowspan="1">Methylphenylsuccinimide (mCPP)</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Mirtazapine</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">n-desmethylcitalopram</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Nor-LAAM</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Noroxymorphone</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Normesuximide</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">PEMA</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Phenazepam</td><td colspan="1" rowspan="1">100,000</td></tr><tr><td colspan="1" rowspan="1">Procaine</td><td colspan="1" rowspan="1">100,000</td></tr></table>

# Interference – Endogenous Compounds and Urine Preservatives

Endogenous compounds and urine preservatives were evaluated in qualitative and semiquantitative modes by spiking the potential interferent into drug free urine containing tapentadol at $\pm 2 5 \%$ of the cutoff. Due to the interference of boric acid observed at $\pm 2 5 \%$ of the cutoff, potential interference was also evaluated at $\pm 5 0 \%$ of the cutoff. Endogenous compounds and urine preservative tested that did not interfere in the assay are presented below.

Non-interfering Endogenous Compounds   

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>ConcentrationTested</td></tr><tr><td rowspan=1 colspan=1>Acetone</td><td rowspan=1 colspan=1>1.0 g/dL</td></tr><tr><td rowspan=1 colspan=1>Ascorbic Acid</td><td rowspan=1 colspan=1>1.5 g/dL</td></tr><tr><td rowspan=1 colspan=1>Bilirubin</td><td rowspan=1 colspan=1>0.002 g/dL</td></tr><tr><td rowspan=1 colspan=1>Creatinine</td><td rowspan=1 colspan=1>0.5 g/dL</td></tr><tr><td rowspan=1 colspan=1>Ethanol</td><td rowspan=1 colspan=1>1.0 g/dL</td></tr><tr><td rowspan=1 colspan=1>Galactose</td><td rowspan=1 colspan=1>0.01 g/dL</td></tr><tr><td rowspan=1 colspan=1>γ-Globulin</td><td rowspan=1 colspan=1>0.5 g/dL</td></tr><tr><td rowspan=1 colspan=1>Glucose</td><td rowspan=1 colspan=1>2.0 g/dL</td></tr><tr><td rowspan=1 colspan=1>Hemoglobin</td><td rowspan=1 colspan=1>0.3 g/dL</td></tr><tr><td rowspan=1 colspan=1>Human SerumAlbumin</td><td rowspan=1 colspan=1>0.5 g/dL</td></tr><tr><td rowspan=1 colspan=1>Oxalic Acid</td><td rowspan=1 colspan=1>0.1 g/dL</td></tr><tr><td rowspan=1 colspan=1>Riboflavin</td><td rowspan=1 colspan=1>0.0075 g/dL</td></tr><tr><td rowspan=1 colspan=1>Sodium Chloride</td><td rowspan=1 colspan=1>6.0 g/dL</td></tr><tr><td rowspan=1 colspan=1>Urea</td><td rowspan=1 colspan=1>6.0 g/dL</td></tr></table>

Non-interfering Urine Preservative   

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>ConcentrationTested</td></tr><tr><td rowspan=1 colspan=1>Sodium Azide</td><td rowspan=1 colspan=1>1% w/v</td></tr><tr><td rowspan=1 colspan=1>SodiumFluoride</td><td rowspan=1 colspan=1>1% w/v</td></tr></table>

Boric acid interference test results at $\pm 5 0 \%$ of the cutoff in qualitative and semi-quantitative modes are presented in below.

# Interference at $\pm 5 0 \%$ of the Cutoff

<table><tr><td rowspan=2 colspan=1>Compound</td><td rowspan=2 colspan=1>ConcentrationTested</td><td rowspan=1 colspan=2>-50% Cutoff (50 ng/mL)</td><td rowspan=1 colspan=2>+50% Cutoff (150 ng/mL)</td></tr><tr><td rowspan=1 colspan=1>QualitativeResult</td><td rowspan=1 colspan=1>Semi-QuantitativeResult</td><td rowspan=1 colspan=1>QualitativeResult</td><td rowspan=1 colspan=1>Semi-QuantitativeResult</td></tr><tr><td rowspan=1 colspan=1>Boric Acid</td><td rowspan=1 colspan=1>1% w/v</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Negative</td></tr></table>

The sponsor includes the following limitation in the labeling: “Boric Acid at $1 \% \mathrm { w / v }$ may cause false negative results. The assay should not be used to test samples which contain boric acid.”

# Interference – pH

To evaluate potential interference from the effect of urine $\mathsf { p H }$ on the assay’s ability to detect tapentadol, device performance in the qualitative and semi-quantitative modes was tested using a range of urine pH values (3.0, 4.0, 5.0, 6.0, 7.0, 8.0, 9.0, 10.0 and 11.0). All test samples were prepared in drug free urine containing tapentadol at $\pm 2 5 \%$ of the cutoff. No positive or negative interference was observed at urine $\mathsf { p H }$ values ranging from 3.0 to 11.0 for each test mode.

4. Assay Reportable Range: Not applicable

5. Traceability, Stability, Expected Values (Controls, Calibrators, or Methods):

The assay calibrators are traceable to a commercially-available, certified, standard material with the concentration verified by GC-MS or LC-MS/MS.

6. Detection Limit: Not applicable

7. Assay Cut-Off: The assay cut-off is $2 0 0 \mathrm { n g / m L }$ of tapentadol in urine.

# B Comparison Studies:

1. Method Comparison with Predicate Device:

A method comparison study was performed using 160 deidentified remnant unaltered clinical urine samples obtained from clinical testing laboratories. The urine samples were analyzed for tapentadol using the Immunalysis Tapentadol Urine HEIA on the Beckman Coulter AU480 chemistry analyzer in both qualitative and semi-quantitative modes and LC-MS/MS (Agilent 6430 Liquid Chromatography-Tandem Mass Spectrometry). The method results of the comparison study showed a positive percent agreement (PPA) and negative percent agreement (NPA) of $100 \%$ and $100 \%$ , respectively. The results are presented below.

Method Comparison Results by Concentration Range   

<table><tr><td rowspan=3 colspan=2>ImmunalysisTapentadol UrineHEIA Result</td><td rowspan=1 colspan=2>LC-MS/MS Ta</td><td rowspan=1 colspan=2>LC-MS/MS Tapentadol Concentration</td></tr><tr><td rowspan=2 colspan=1>&lt;100ng/mL(less than-50%cutoff)</td><td rowspan=1 colspan=1>100 - 199</td><td rowspan=1 colspan=1>200 - 300</td><td rowspan=1 colspan=1>&gt; 300</td></tr><tr><td rowspan=1 colspan=1>ng/mL(between -50%cutoffandcutoff)</td><td rowspan=1 colspan=1>ng/mL(betweencutoff and+50%cutoff)</td><td rowspan=1 colspan=1>ng/mL(greaterthan +50%cutoff)</td></tr><tr><td rowspan=2 colspan=1>Qualitative</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>81</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>46</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Semi-Quantitative</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>81</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>46</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

2. Matrix Comparison:

Not applicable. The assay is intended for use only with urine samples.

# C Clinical Studies:

1. Clinical Sensitivity: Not applicable

2. Clinical Specificity: Not applicable

3. Other Clinical Supportive Data (When 1. and 2. Are Not Applicable): Not applicable

D Clinical Cut-Off: Not applicable   
E Expected Values/Reference Range: Not applicable

# VIII Proposed Labeling:

The labeling supports the finding of substantial equivalence for this device.

# IX Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.